La cadena de opciones muestra datos clave de las opciones de acciones de Nixxy a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Nixxy..

Nixxy (NASDAQ:NIXX) Bolsa, Cadena de Opciones

Nixxy

Recruiter.Com Group

Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.

Nixxy Inc

General

ENVX

Enovix Ships EX-2M Samples To Mobile Phone Customers

WIIM

APLM

Apollomics shares are trading lower after the company announced its Phase 3 bridging trial of Uproleselan in China did not demonstrate a favorable benefit.

The Federal Reserve&#8217;s key inflation measure came in below expectations for November, delivering welcome relief Friday to markets after the central bank warned earlier this week of mounting price pressures heading <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42598354/wall-street-pins-hopes-on-fridays-crucial-fed-inflation-report-yet-a-miracle-is-needed-to-shift-the-narrative">into the new year.</a>
The Personal Consumption Expenditures price index grew by 2.4% in November 2024 on a year-over-year basis, up from 2.3% in October, according to government data. The figure missed economist forecasts of 2.5%, yet it marked the second consecutive monthly increase in this key inflation measure.
On a monthly basis, the PCE index advanced 0.1%, decelerating from October's 0.2%. 
Excluding volatile components like food and energy, core PCE held steady at 2.8% year-over-year, below expectations of 2.9%. On a monthly basis, core PCE growth slowed to 0.1%, down from the prior 0.3% and below expectations of 0.2%.
In tandem with the inflation data, the report also showed that personal income rose 0.3% month-over-month in November, slowing from October's 0.5% increase and missing expectations of 0.4%. Personal spending grew by 0.4%, slightly below forecasts but in line with October's increase, signaling resilient consumer activity heading into the holiday season.
<h3 class="wp-block-heading">Another Reality Check For Markets</h3>
The unexpectedly softer November PCE reading could provide relief after days of heightened market volatility triggered by this week&#8217;s Federal Reserve meeting.
On Wednesday, the Fed signaled a slower pace of rate cuts and raised its inflation projections for 2025 and beyond, reinforcing its hawkish stance.
Policymakers now forecast headline PCE inflation to reach 2.5% next year, up from the September projection of 2.1%, and 2.1% in 2026, compared to the previous 2% estimate. Similarly, core PCE inflation is now expected to hit 2.5% in 2025, up from 2.2%, and 2.1% in 2026, revised from 2%.
Fed Chair Jerome Powell's remarks further dashed market hopes when he announced a "new phase" in monetary policy, signaling caution against easing further as interest rates approach the neutral level.
Prior to Friday's data release, money markets had priced in 65 basis points of cumulative rate cuts for next year. 
<h3 class="wp-block-heading">Dollar Falls, Equity Futures Trim Losses</h3>
<ul>
<li>The U.S. dollar index (DXY) – as tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – tumbled 0.3%. </li>
<li>Futures on major U.S. indices trimmed premarket losses, with contracts on the S&amp;P 500 down by 0.7% at 8:35 a.m. in New York. On Thursday the S&amp;P 500 – as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – closed 0.1% lower, bringing its cumulative decline since the Fed&#8217;s meeting to over 3%.</li>
<li>Gold surged by 0.6% to $2,610 per ounce. </li>
<li>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slightly rebounded after the news to above $95,000 levels, cutting daily losses to 2%. Prior to this week&#8217;s Fed meeting, the largest cryptocurrency had reached an all-time high of $108,364. </li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42611748/us-stocks-to-open-lower-as-traders-brace-for-triple-witching-hour-analyst-says-end-of-the-year-recovery-would-not-surprise-anyone">US Stocks To Open Lower As Traders Brace For &#8216;Triple Witching&#8217; Hour: Analyst Says End Of The Year Recovery &#8216;Would Not Surprise Anyone&#8217;</a></li>
</ul>
Photo via Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

Markets

ETFs

$BTC

PowerShares DB US Dollar Index Bullish Fund

Fed's Preferred Inflation Gauge Falls More Than Expected: Markets Breathe Sigh Of Relief

BNZI

Banzai shares are trading higher after the company announced it has signed an agreement to acquire Vidello.

Occidental Petroleum shares are trading higher after Berkshire Hathaway increased its stake in the company.

The role of stablecoins in transforming global payments emerged as a central theme during a panel discussion at the <a href="https://benzinga.swoogo.com/digital-assets/agenda-2024">Benzinga Future of Digital Assets</a> conference. Panelist Jan van Eck, CEO of VanEck, described stablecoins as a driving force behind a new financial system, particularly in regions where traditional banking systems are less efficient.
"The global payments system is being rewired as we speak, and people are using stablecoins as the backbone," van Eck said, highlighting their impact on cross-border transactions and financial inclusion.
<h4 class="wp-block-heading">Stablecoins And Global Adoption</h4>
Van Eck emphasized the rapid adoption of stablecoins in emerging markets, which are increasingly used for foreign exchange and remittances. He pointed out that their transaction volume is now approaching double that of Visa, signaling their importance in global commerce. Despite this growing adoption, van Eck noted that stablecoin usage remains underappreciated in the United States, where traditional banking systems dominate.
One example he mentioned was the inefficiency of U.S. banking operations during national holidays. "Imagine a day like Veterans Day when no money can move between institutions in the United States. That world will be gone in three to five years."
<h4 class="wp-block-heading">The Role Of Regulation</h4>
While stablecoins present clear benefits, regulatory clarity remains a challenge. Van Eck expressed concerns over the potential for restrictive legislation, particularly if influenced by banking lobbyists. "I prefer them [legislators] to be completely passive," he said, emphasizing his concern that new laws could create unnecessary barriers to adoption. "The banking regulators love control. Jamie Dimon loves control."
The fight over crypto regulation in the U.S. continues to be contested among banking, securities and commodity regulators. Van Eck argued that the Securities and Exchange Commission has mishandled the digital asset space, allowing commodity regulators to take a leading role. Despite these challenges, he sees stablecoins as a critical tool for global financial systems.
<h4 class="wp-block-heading">Implications For Financial Advisors</h4>
Van Eck also addressed questions from financial advisors about integrating stablecoins into client accounts, noting that existing infrastructure like Charles Schwab may not be equipped to handle these assets directly. However, he anticipates that third-party platforms will fill the gap, enabling wider adoption within the traditional financial ecosystem.
He highlighted the importance of developing software solutions to streamline the integration of stablecoins into existing systems. "Clients are going to want it," van Eck said, predicting that financial institutions will need to adapt quickly to meet this demand.
<h4 class="wp-block-heading">A Future Built On Stablecoins</h4>
Stablecoins&#8217; potential extends beyond individual transactions. Van Eck described them as a foundation for broader financial infrastructure, particularly in markets where traditional banking systems are failing. By enabling faster, cheaper and more efficient transfers, stablecoins could become essential to the global economy.
"Stablecoin usage is exploding," Van Eck concluded, emphasizing its potential to reshape how value is transferred worldwide. As adoption increases, the industry must overcome regulatory hurdles to unlock the full benefits of this transformative technology.
Image: Shutterstock

Events

Exclusives

'The Global Payments System Is Being Rewired' — What's Next For Stablecoins?

On Thursday, Aadi Bioscience, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AADI#NASDAQ">AADI</a>) entered into an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics and&nbsp;Hangzhou&nbsp;DAC Biotechnology Co., Ltd.
Per the terms of the license agreement, Aadi is granted exclusive rights to certain patents and know-how pertaining to three preclinical ADC programs leveraging Hangzhou&nbsp;DAC&#8217;s CPT113 linker payload technology.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36262600/cancer-player-aadi-bioscience-downgraded-analyst-highlights-worse-than-expected-res" rel="noreferrer noopener">Cancer Player Aadi Bioscience Downgraded: Analyst Highlights ‘Worse Than Expected' Response Rates</a>.
Aadi will pay aggregate upfront payments of&nbsp;$44 million&nbsp;for in-<a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42607146/aadi-bioscience-transforms-with-in-licensing-of-novel-adc-portfolio-100-million-sale-of-fyarro-and" rel="noreferrer noopener">licensing such ADC programs</a>.
Additionally, Aadi will pay cumulative development milestone payments of up to&nbsp;$265 million, cumulative commercial milestone payments of up to&nbsp;$540 million, and single-digit sales royalties.
To support this transaction, Aadi entered into a subscription agreement with certain qualified institutional buyers and accredited investors for a private investment in public equity financing of approximately&nbsp;$100 million.
The company is selling 21.59 million shares at $2.40&nbsp;per share.
In August, Aadi Bioscience&nbsp;announced it would halt the registration-intended PRECISION1 trial of&nbsp;nab-sirolimus in patients with solid tumors harboring&nbsp;TSC1&nbsp;or&nbsp;TSC2&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40484716/cancer-focused-aadi-bioscience-stock-plunges-as-solid-tumor-trial-falls-short-of-expectations" rel="noreferrer noopener">inactivating alterations</a>.
An analysis by the Independent Data Monitoring Committee demonstrated that the study was unlikely to exceed an efficacy threshold necessary to support an accelerated approval, the key goal of this Phase 2 study.&nbsp;
Price Action: AADI stock is up 24.1% at $2.87 during the premarket session at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42613640/fda-approves-ionis-pharmaceuticals-rare-genetic-disease-therapy-to-lower-high-level-of-fat-in-blood" target="_blank" rel="noreferrer noopener">FDA Approves Ionis Pharmaceuticals&#8217; Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood</a></li>
</ul>

Biotech

News

Health Care

Financing

Offerings

Contracts

Movers

Trading Ideas

AADI

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

SPAI

Safe Pro shares are trading higher after the company announced its expectation to report 2024 revenue exceeding $2 million, representing over 130% growth.

Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) shares closed slightly lower <a href="https://www.benzinga.com/tech/24/12/42547442/microsof-scoops-up-485000-nvidia-ai-chips-twice-as-many-as-its-closest-rival-meta-report">during Thursday's session</a>.
Microsoft has reportedly acquired nearly twice as many Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) AI chips as its closest competitors. This strategic investment is aimed at bolstering its AI capabilities, particularly for its Azure cloud services.
On Wednesday, UBS analyst Karl Keirstead maintained Microsoft with a Buy rating and raised the price target from $500 to $525, while Stifel analyst Brad Reback maintained the stock with a Buy and increased the price target from $475 to $515.
With the recent buzz around Microsoft, some investors may be eyeing potential gains from the company's dividends too. As of now, Microsoft offers an annual dividend yield of 0.76%, which is a quarterly dividend amount of 83 cents per share ($3.32 a year).
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $789,713 or around 1,807 shares. For a more modest $100 per month or $1,200 per year, you would need $157,768 or around 361 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($3.32 in this case). So, $6,000 / $3.32 = 1,807 ($500 per month), and $1,200 / $3.32 = 361 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
MSFT Price Action: Shares of Microsoft slipped 0.1% to close at $437.03 on Thursday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42582254/top-3-consumer-stocks-you-may-want-to-dump-this-quarter">Top 3 Consumer Stocks You May Want To Dump This Quarter</a></li>
</ul>
Photo: Shutterstock

Long Ideas

MSFT

NVDA

How To Earn $500 A Month From Microsoft Stock

~Acquisition provides Woodward industry-proven electromechanical technology platform for next generation aircraft. It is a step forward for Safran towards the acquisition of Collins Aerospace actuation and flight control activities~

Woodward To Acquire Safran's Electromechanical Actuation Business Based in North America; Amount Not Disclosed

Fed's Williams Say We Have Seen Good Progress On Inflation, But Recent Data A Touch Higher;  There Is A Lot Of Uncertainty Around Inflation; There Is A Lot Of Uncertainty Around Future Fiscal Policy; Has Started Bringing In How Fiscal Policy Will Affect Economy; Our Economy Is Doing Well And That's Pushed Up Longer Term Yields

TRUG

TruGolf Collaborates With D3 Sports Tech Announce Plans To Focus On Innovations And Enhance Gameplay

INCR

InterCure Secures Funding Commitments Of NIS 66M To Support Nir Oz Facility Recovery

Fed's Williams Say Monetary Policy Is 'Well Positioned,' Is Somewhat Restrictive; Fed Will Have To Be Data Dependant As It Sets Policy

Fed's Williams Say Seeing Encouraging News On Economy But Journey Has Been Bumpy; Will Make Sure Fed Gets Inflation To 2%;  Recent Data Consistent With Fed's Economic Projections; Economy Is In Good Place; For Next Year Expects Growth To Slow To 2%, Steady Unemployment Rate; Hopes Disinflation Process Will Continue, But Lots Of Uncertainty

Wells Fargo analyst Tiago Fauth maintains Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) with a Overweight and raises the price target from $75 to $88.

Price Target

Analyst Ratings

RARE

Wells Fargo Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $88

IIPR

Innovative Industrial Properties shares are trading higher after the company reported a default by Pharmacann on its obligations to pay rent for six of its eleven leases in December.

TCBP

TC BioPharm Completes Full-Dose Regimen In ACHIEVE Phase 2b Clinical Trial

SIDU

Sidus Space Announces LizzieSat-2 To Launch Dec. 21, 2024 On The Bandwagon-2 Rideshare Mission With SpaceX

ASNS

Actelis Networks Launches MetaShield, AI-Based Cybersecurity Solution To Drive SaaS Growth And Edge Infrastructure Resilience

Nixxy shares fall as co reports CognoGroup spin-off plans

Recruiter.Com Group, Inc. ( ($NIXX) ) has released its Q3 earnings. Here is a breakdown of the information Recruiter.Com Group, Inc. presented to i...

Nixxy, Inc. Reports Shift and Challenges in Latest Earnings

Nixxy (NIXX) is offering up to 20M shares of common stock at an assumed offering price of $3.21 per share, which is equal average of the high and l...

Nixxy files to sell 20M shares of common stock

Nixxy ( ($NIXX) ) has shared an update. Granger Whitelaw has resigned from his roles as a member of the Board of Directors and as Chief Executive O...

Nixxy CEO Granger Whitelaw Resigns, Successor Search Begins

Nixxy CEO Granger Whitelaw resigns

On December 12, Granger Whitelaw resigned from his positions as member of the Board of Directors of Nixxy (NIXX) effective immediately, and as Chie...

Nixxy announces CEO Granger Whitelaw resigns from his positions

NIXX

Press Releases

Nixxy Issues Shareholder Update For Strategic Focus And Acquisition Progress

Nixxy Signs Letter Of Intent to Acquire Privately Held Company in the Wholesale Gifts Business

5 Must-Watch Stocks Under $5: NIXX, PRSO, VSME, BREA, STAF

Nixxy Announces CognoGroup Spin-Off Plans

Peraso Inc. (NASDAQ: PRSO): Revolutionizing Military Combat with Steerable Beam Technology see more stocks inside…

Nixxy Details Strategic Growth, JustGot2HaveIt Acquisition Updates, and CognoGroup Spin-Off Record Date

Comments

Nixxy

Nixxy (NIXX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL